Skip to main content
SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
54,000
-400 (-0.74%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Vaccines and Biopharmaceuticals
267.55B
Log In
Log In
Log In
Log In
Upgrade
Vaccines and Biopharmaceuticals Growth
-27.59%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
South Korea
131.49B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-16.89%
Log In
Log In
Log In
Log In
Upgrade
Europe
107.12B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
405.26%
Log In
Log In
Log In
Log In
Upgrade
America
24.80B
Log In
Log In
Log In
Log In
Upgrade
America Growth
-86.66%
Log In
Log In
Log In
Log In
Upgrade
Asia
3.55B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-8.81%
Log In
Log In
Log In
Log In
Upgrade
Middle East
576.98M
Log In
Log In
Log In
Log In
Upgrade
Middle East Growth
149.11%
Log In
Log In
Log In
Log In
Upgrade